CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
Published on June 21, 2024
VOLITIONRX LIMITED
1489 West Warm Springs Road, Suite 110
Henderson, Nevada 89014
June 21, 2024
SUBMITTED VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Mr. Chris Edwards
|
| Re: | VolitionRx Limited Acceleration Request |
|
|
| Registration Statement on Form S-3 |
|
|
| Filed June 14, 2024 |
|
|
| File No. 333-280217 |
|
| Requested Date: | June 25, 2024 |
|
| Requested Time: | 5:00 P.M. Eastern Time |
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended (the “Securities Act”), VolitionRx Limited, a Delaware corporation (the “Company”), hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the above-captioned Registration Statement on Form S-3 effective at the “Requested Date” and “Requested Time” set forth above, or as soon thereafter as practicable.
Should the Commission have any questions regarding this acceleration request, please do not hesitate to contact Marc G. Alcser, an attorney with the Company’s outside legal counsel, Stradling Yocca Carlson & Rauth LLP, via telephone at (949) 725-4136 or via email at malcser@stradlinglaw.com. We respectfully request that you contact Mr. Alcser via telephone as soon as the above referenced Registration Statement has been declared effective.
| Sincerely,
VOLITIONRX LIMITED | |||
| /s/ Cameron Reynolds | |||
|
|
|
|
|
|
|
| Cameron Reynolds | |
| President and Chief Executive Officer |
cc:
VolitionRx Limited
Terig Hughes, Chief Financial Officer
Stradling Yocca Carlson & Rauth LLP
Marc G. Alcser, Esq.